Procedure
DPC
DPC is a medical procedure with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
completed267%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
withdrawnnot_applicable
A Study to Reduce the Reflux After a Sleeve Gastrectomy in Obese Patients
NCT04287972
completedphase_1
Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors
NCT02688101
completednot_applicable
The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy
NCT00187850
Clinical Trials (3)
Showing 3 of 3 trials
NCT04287972Not Applicable
A Study to Reduce the Reflux After a Sleeve Gastrectomy in Obese Patients
NCT02688101Phase 1
Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors
NCT00187850Not Applicable
The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3